Exponent (NASDAQ:EXPO - Get Free Report)'s stock had its "hold (c-)" rating reissued by equities researchers at Weiss Ratings in a report issued on Wednesday,Weiss Ratings reports.
Exponent Stock Performance
NASDAQ EXPO opened at $66.60 on Wednesday. The company has a market cap of $3.36 billion, a P/E ratio of 33.30 and a beta of 0.91. The business's 50 day moving average price is $70.09 and its 200-day moving average price is $74.50. Exponent has a fifty-two week low of $63.81 and a fifty-two week high of $115.75.
Exponent (NASDAQ:EXPO - Get Free Report) last released its earnings results on Thursday, July 31st. The business services provider reported $0.52 earnings per share for the quarter, beating the consensus estimate of $0.48 by $0.04. The firm had revenue of $132.87 million for the quarter, compared to the consensus estimate of $130.82 million. Exponent had a return on equity of 24.19% and a net margin of 18.35%.The company's revenue for the quarter was up 7.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.57 EPS. As a group, equities analysts predict that Exponent will post 1.98 EPS for the current year.
Insiders Place Their Bets
In other Exponent news, CEO Catherine Corrigan sold 4,905 shares of the stock in a transaction on Monday, September 15th. The stock was sold at an average price of $69.91, for a total value of $342,908.55. Following the sale, the chief executive officer owned 82,753 shares in the company, valued at $5,785,262.23. This trade represents a 5.60% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, VP Joseph Sala sold 1,595 shares of the stock in a transaction on Tuesday, August 12th. The stock was sold at an average price of $70.64, for a total value of $112,670.80. The disclosure for this sale can be found here. In the last quarter, insiders sold 11,396 shares of company stock worth $803,636. Insiders own 1.60% of the company's stock.
Institutional Trading of Exponent
A number of hedge funds and other institutional investors have recently bought and sold shares of EXPO. GAMMA Investing LLC grew its position in shares of Exponent by 8,065.9% during the 1st quarter. GAMMA Investing LLC now owns 33,072 shares of the business services provider's stock worth $2,681,000 after buying an additional 32,667 shares in the last quarter. UMB Bank n.a. grew its position in shares of Exponent by 859.1% during the 1st quarter. UMB Bank n.a. now owns 633 shares of the business services provider's stock worth $51,000 after buying an additional 567 shares in the last quarter. Portside Wealth Group LLC grew its position in shares of Exponent by 6.0% during the 1st quarter. Portside Wealth Group LLC now owns 2,993 shares of the business services provider's stock worth $243,000 after buying an additional 170 shares in the last quarter. Farther Finance Advisors LLC grew its position in shares of Exponent by 29.9% during the 1st quarter. Farther Finance Advisors LLC now owns 3,274 shares of the business services provider's stock worth $265,000 after buying an additional 753 shares in the last quarter. Finally, SG Americas Securities LLC bought a new position in shares of Exponent during the 1st quarter worth $665,000. Hedge funds and other institutional investors own 92.37% of the company's stock.
Exponent Company Profile
(
Get Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
